TVB-2640
3V2640-CLIN-002
Phase 1 small_molecule completed
Quick answer
TVB-2640 for Solid Malignant Tumor is a Phase 1 program (small_molecule) at Sagimet Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sagimet Biosciences
- Indication
- Solid Malignant Tumor
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed